(S)-3-(1-Oxo-5-(piperazin-1-yl)isoindolin-2-yl)piperidine-2,6-dione hydrochloride
95%
- Product Code: 233362
CAS:
2520107-65-5
| Molecular Weight: | 364.83 g./mol | Molecular Formula: | C₁₇H₂₁ClN₄O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, seal, inert gas |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of immunomodulatory drugs, particularly those targeting protein degradation pathways such as cereblon E3 ligase modulators. It plays a role in the development of compounds with potential anticancer and anti-inflammatory activity. Its structure supports targeted protein degradation, making it valuable in the design of PROTACs (proteolysis-targeting chimeras) and other therapeutic agents aimed at difficult-to-treat diseases.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50mg | 10-20 days | ฿20,710.00 |
+
-
|
(S)-3-(1-Oxo-5-(piperazin-1-yl)isoindolin-2-yl)piperidine-2,6-dione hydrochloride
Used in pharmaceutical research as a key intermediate in the synthesis of immunomodulatory drugs, particularly those targeting protein degradation pathways such as cereblon E3 ligase modulators. It plays a role in the development of compounds with potential anticancer and anti-inflammatory activity. Its structure supports targeted protein degradation, making it valuable in the design of PROTACs (proteolysis-targeting chimeras) and other therapeutic agents aimed at difficult-to-treat diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :